du Bois A - Search Results

1

Cisplatinum rechallenge in relapsed ovarian cancer patients with platinum reinduction therapy and carboplatin hypersensitivity.

Kandel MJ, Loehr A, Harter P, Traut A, Gnauert K, du Bois A. Kandel MJ, et al. Among authors: du bois a. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):780-4. doi: 10.1111/j.1525-1438.2005.00136.x. Int J Gynecol Cancer. 2005. PMID: 16174224 Free article.

2

Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer.

du Bois A, Meerpohl HG, Madjar H, Spinner D, Dall P, Pfisterer J, Bauknecht T. du Bois A, et al. J Cancer Res Clin Oncol. 1994;120(3):173-8. doi: 10.1007/BF01202198. J Cancer Res Clin Oncol. 1994. PMID: 8263015 Clinical Trial.

3

Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer.

du Bois A, Lück HJ, Bauknecht T, Möbus V, Bochtler H, Diergarten K, Meerpohl HG. du Bois A, et al. Ann Oncol. 1997 Apr;8(4):355-61. doi: 10.1023/a:1008267419453. Ann Oncol. 1997. PMID: 9209665 Free article. Clinical Trial.

4

[Anthracyclines in therapy of ovarian carcinoma: a systematic review of primary and 2nd-line therapy after platinum].

du Bois A, Lück HJ, Pfisterer J, Meier W, Bauknecht T. du Bois A, et al. Zentralbl Gynakol. 2000;122(5):255-67. Zentralbl Gynakol. 2000. PMID: 10857212 Review. German.

5

The integration of anthracyclines in the treatment of advanced ovarian cancer.

Lück HJ, Du Bois A, Weber B, Pfisterer J, Goupil A, Kuhn W, Barats JC, Blohmer J, Mousseau M, Schröder W, Meier W, Möbus V, Richter B; AGO-GINECO Intergroup. Lück HJ, et al. Among authors: du bois a. Int J Gynecol Cancer. 2001;11 Suppl 1:34-8. Int J Gynecol Cancer. 2001. PMID: 11489001

6

Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer--a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group.

du Bois A, Lück HJ, Pfisterer J, Schroeder W, Blohmer JU, Kimmig R, Moebus V, Quaas J. du Bois A, et al. Ann Oncol. 2001 Aug;12(8):1115-20. doi: 10.1023/a:1011605008922. Ann Oncol. 2001. PMID: 11583193 Free article.

7

Treatment of advanced ovarian cancer.

du Bois A. du Bois A. Eur J Cancer. 2001 Dec;37 Suppl 9:S1-7. doi: 10.1016/s0959-8049(01)00328-8. Eur J Cancer. 2001. PMID: 11741767 Review.

8

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

du Bois A, Lück HJ, Meier W, Adams HP, Möbus V, Costa S, Bauknecht T, Richter B, Warm M, Schröder W, Olbricht S, Nitz U, Jackisch C, Emons G, Wagner U, Kuhn W, Pfisterer J; Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group. du Bois A, et al. J Natl Cancer Inst. 2003 Sep 3;95(17):1320-9. doi: 10.1093/jnci/djg036. J Natl Cancer Inst. 2003. PMID: 12953086 Clinical Trial.

9

Improving first-line therapy of advanced ovarian cancer - the AGO Ovarian Cancer Study Group perspective.

du Bois A, Pfisterer J, Meier W, Wagner U. du Bois A, et al. Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:169-71. doi: 10.1111/j.1525-1438.2003.t01-2-13352.x. Int J Gynecol Cancer. 2003. PMID: 14656275

10

[First-line therapy in ovarian cancer].

du Bois A, Pfisterer J. du Bois A, et al. Zentralbl Gynakol. 2004 Oct;126(5):312-4. doi: 10.1055/s-2004-820390. Zentralbl Gynakol. 2004. PMID: 15478049 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

561 results

Search Page